Peanut Butter: The Unexpected Anti-Aging Ally

Peanut butter just became a secret weapon against the frailty that steals independence from seniors—without adding a single pound.

Story Snapshot

Deakin University RCT shows 43g daily peanut butter cuts sit-to-stand time by 1.23 seconds in fall-risk adults aged 66-89.
Boosts lower-body muscle power for easier stair climbing and chair rising, key to preventing falls.
86% adherence rate with no weight gain despite extra protein and fats.
First direct RCT on peanut butter for sarcopenia, distinguishing it from prior nut studies.

COINS Trial Details and Results

Deakin University’s Institute for Physical Activity and Nutrition ran the COINS trial from 2022 to 2025. Researchers recruited 120 community-dwelling adults aged 66-89 at high fall risk. Participants ate 43 grams of natural peanut butter daily—roughly three tablespoons—or stuck to usual care for six months. The peanut group improved five-times sit-to-stand performance by 1.23 seconds (p=0.006). Lower-body muscle power rose significantly, aiding explosive movements needed for daily life. No changes appeared in gait speed, handgrip strength, or body composition.

Why Peanut Butter Counters Sarcopenia

Sarcopenia shrinks muscle mass and power after age 60, raising fall risks and eroding independence. Peanut butter delivers 7 grams of protein per serving, rich in leucine that triggers muscle repair. Unsaturated fats like MUFAs and PUFAs fight oxidative stress. Antioxidants protect muscle cells. Fat oxidation and thermogenesis offset added calories, explaining zero weight gain.

Preceding Peanut Research Builds Case

Auburn University tested peanut powder with resistance training in 2021, boosting muscle growth and strength in older adults. A 2022 trial found 30 grams of peanuts with skins enhanced endurance and workload. The 2023 Nutrients study showed peanut proteins cut exercise fatigue through lower oxidative stress. University of South Australia research linked daily peanuts to weight loss, better blood pressure, and glucose control. These set the stage for COINS as the first peanut butter-specific RCT targeting function.

Stakeholders Drive Evidence and Awareness

Dr. Sze-Yen Tan, Deakin IPAN associate professor, led COINS to fill the RCT gap on nuts for physical function. Deakin IPAN focuses on nutrition and activity intersections. The Peanut Institute, a U.S. peanut research promoter, released findings on March 3, 2026, via PRNewswire. Dr. Samara Sterling there champions peanuts for muscle building across ages. Peer-reviewed publication in Journal of Cachexia, Sarcopenia and Muscle ensures academic rigor, while industry amplifies real-world reach without noted conflicts.

Expert Views and Cautions

Dr. Tan notes muscle power gains enable stair climbing and cut falls, though gait speed stayed flat. Handgrip strength neared significance per-protocol (p=0.055). Dr. Roberts from Auburn endorses peanuts with training to prevent loss. Peanut Institute highlights leucine for repair. Experts call for larger trials on low-protein seniors and biomarkers. Facts support feasibility and no weight gain universally; press emphasis on positives holds given peer-reviewed backing and affordability.

Implications for Healthy Aging

Seniors gain an easy add-on for muscle power, targeting fall-prone community dwellers. Short-term, it promises better mobility without diet overhauls. Long-term, it bolsters plant-based protein guidelines amid rising sarcopenia costs. Peanut industry sees sales lift from validated benefits. Broader nut sector advances versus pricier alternatives. High adherence proves real-world fit, urging trials on diverse groups.